Armin Schulz
Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.
After graduating, he worked as an IT consultant for a listed company before becoming self-employed, during which time he worked for various DAX-listed companies and a large Swiss insurance company, among others.
Since 2009, he has been exclusively involved in the capital markets, where he was able to gain experience as a day and swing trader, in investor relations and at board level. He was able to live out his passion for numbers in the controlling department of a securities trading house.
For him, fundamental analysis paired with the correct reading of the price action of a market provides the basis for successful trading.
Commented by Armin Schulz
Commented by Armin Schulz on July 15th, 2025 | 07:25 CEST
After tungsten, is this the next raw material bottleneck? thyssenkrupp, Pasinex Resources, and Mercedes-Benz under review!
Geopolitical tensions are forcing industrialized nations to radically rethink their strategies. Following strategic metals like tungsten and rare earths, another raw material is coming into the spotlight. The importance of steel refinement and high-tech production is growing exponentially, while supply risks are looming due to market concentration. Those who now secure alternative supply sources or develop substitution technologies will not only secure supply chains but also generate competitive advantages. We take a closer look at companies that rely on zinc, and one company that could help the US remove zinc from its list of critical raw materials.
Read
Commented by Armin Schulz on July 15th, 2025 | 07:15 CEST
Hydrogen at a crossroads: Plug Power, Pure Hydrogen, and Nel ASA between opportunity and crisis – Your profit strategy
The hydrogen industry is facing a critical turning point in 2025. Despite massive political support and growing global market volume, companies are struggling with profitability gaps and regulatory hurdles. The widening gap between ambition and implementation is becoming an existential threat. Only those who successfully master innovation, scalability, and infrastructure connectivity will survive the upcoming market shakeout. In this tense environment, it will be determined who can truly capitalize on the billion-dollar opportunities of green hydrogen – and who will be left behind. We take a look at Plug Power, Pure Hydrogen, and Nel ASA and analyze their path forward.
Read
Commented by Armin Schulz on July 14th, 2025 | 07:00 CEST
Capitalizing on the central bank gold rush: Barrick Mining's production, Dryden Gold's exploration, and Deutsche Bank's interest rate concerns
Gold is once again shining as a strategic anchor in turbulent times. Global central banks, especially those in emerging markets, are massively expanding their reserves, driven by geopolitical risks, currency diversification, and inflation concerns. At the same time, central banks like the ECB are lowering interest rates, which on the one hand offers banks cheaper refinancing, but on the other hand squeezes margins and increases credit risks. This dynamic mix of a gold rush, monetary policy shift, and inflationary pressure is forcing financial players to rethink their strategies. In this context, we take a look at two gold companies, Barrick Mining and Dryden Gold, and analyze the current outlook for Deutsche Bank.
Read
Commented by Armin Schulz on July 11th, 2025 | 07:05 CEST
Rheinmetall, Argo Graphene Solutions, Vonovia: Three beneficiaries of the EUR 500 billion stimulus package
Germany's economy is facing a billion-dollar gamble. Government super-write-offs and a EUR 500 billion special fund are fueling investment in infrastructure and defense. Record budgets of EUR 115 billion for roads, networks, and education, as well as EUR 86 billion for arms modernization, are creating unprecedented opportunities. Those who join now can benefit from Germany's largest restructuring in decades. But where are the best prospects? Today, we look at three companies that could profit from these investments in defense and infrastructure: Rheinmetall, Argo Graphene Solutions, and Vonovia.
Read
Commented by Armin Schulz on July 10th, 2025 | 07:15 CEST
How BioNTech, PanGenomic Health, and Pfizer are using artificial intelligence to cut costs and boost returns
Digitalization is revolutionizing the biotechnology and pharmaceutical industries. Artificial intelligence sifts through billions of pieces of medical data in real time, accelerating drug development by years. This is also demonstrated by the new alliance between Moderna and Google Cloud, which are jointly developing an AI platform for customized mRNA cancer therapies. These technologies reduce production costs by up to 40% and generate disruptive return opportunities. At the same time, personalized medicine is opening up billion-dollar markets. Three companies are turning to artificial intelligence to boost their returns: BioNTech, PanGenomic Health, and Pfizer.
Read
Commented by Armin Schulz on July 10th, 2025 | 07:05 CEST
Deutsche Telekom, MiMedia, Xiaomi: Three stocks benefiting from the cloud and AI revolution
By 2025, cloud services and artificial intelligence (AI) will become increasingly important. AI infrastructures have become a critical competitive nerve center. Hyperscaling and agentic systems are revolutionizing value chains; those who hesitate will lose out. The drivers are platforms such as Microsoft's new AI cloud generation, which enables the real-time integration of generative AI into core processes. This hyperscaling reduces costs, enhances data protection, and accelerates AI adoption in data-intensive sectors. A billion-dollar market is emerging for pioneers. Three players have strategically positioned themselves: Deutsche Telekom, MiMedia, and Xiaomi.
Read
Commented by Armin Schulz on July 9th, 2025 | 07:05 CEST
Liver cancer breakthrough fuels billion-dollar market: How Bayer, Vidac Pharma, and Novo Nordisk can now power your portfolio
The pharmaceutical industry is undergoing its biggest upheaval in decades. Megatrends such as cancer treatment, fueled by recent breakthroughs like the EMA approval of the liver cancer therapy Lenvima®/Keytruda®, and revolutionary therapies for diabetes and obesity are generating billion-dollar markets. Those who understand these growth drivers will identify lucrative opportunities. Innovative active ingredients are not only changing medicine but also unlocking exceptional return potential for forward-thinking investors. This dynamic draws attention directly to the strategies of Bayer, Vidac Pharma, and Novo Nordisk.
Read
Commented by Armin Schulz on July 8th, 2025 | 07:00 CEST
Tungsten and molybdenum for the US military and Elon Musk: Why Almonty's NASDAQ listing could provide the next boost
Tungsten is harder than steel and only melts at 3,422 degrees - no wonder it is used in rockets, industrial robots, semiconductors, and many other high-tech applications. However, 84% of the world's critical metal comes from China, which poses a strategic risk to the West. Since the Chinese government imposed export restrictions, there has been significant upheaval. This is where Almonty Industries comes in. With mines in South Korea, Portugal, and Spain, the Company is building the largest independent tungsten pipeline outside China. For investors, Almonty is thus becoming a lever for raw material independence.
Read
Commented by Armin Schulz on July 7th, 2025 | 07:10 CEST
RENK, Globex Mining, BYD: The raw materials gap – A threat to defense and e-mobility, An opportunity for miners
Global industry is facing a turning point. While defense giants like RENK are experiencing record demand yet continue to face investor skepticism, and electric vehicle leader BYD grapples with market saturation, raw materials are redefining the competitive landscape. Raw materials such as tungsten, antimony, and rare earths are essential for high-tech industries. Globex Mining is directly benefiting from this shortage of strategic metals – an effect that is permeating supply chains, from tank manufacturing to electric vehicle production. The diverging paths of these three players underscore the importance of supply security in determining success. An analysis of the current status of RENK, Globex Mining, and BYD reveals the strategic levers for future value creation.
Read
Commented by Armin Schulz on July 3rd, 2025 | 07:20 CEST
Desert Gold's ingenious move: How the untapped gold anomaly and upcoming PEA could significantly enhance your portfolio
What if there were a vast, largely unexplored area right next to some of West Africa's most productive gold mines? And what if strong gold traces had already been found on surface, but no drill had ever been set up there? Desert Gold Ventures is now seizing this opportunity with the Tiegba Project in Ivory Coast. The deal is more than just a new exploration field. It is a strategically astute move with the potential to fundamentally transform the Company. Investors looking for exceptional opportunities in the commodities sector would be well advised to take a closer look.
Read